Dial-in Number

  • One tap mobile
    +13126266799,,3231998494# US (Chicago)
    +13462487799,,3231998494# US (Houston)
  • Dial by your location
    +1 312 626 6799 US (Chicago)
    +1 346 248 7799 US (Houston)
    +1 669 900 6833 US (San Jose)
    +1 929 436 2866 US (New York)
    +1 253 215 8782 US
    +1 301 715 8592 US
    Meeting ID: 323 199 8494
    Find your local number:

Web session

HL7 Antitrust Policy

Professional Associations, such as HL7, which bring together competing entities are subject to strict scrutiny under applicable antitrust laws. HL7 recognizes that the antitrust laws were enacted to promote fairness in competition and, as such, supports laws against monopoly and restraints of trade and their enforcement. Each individual participating in HL7 meetings and conferences, regardless of venue, is responsible for knowing the contents of and adhering to the HL7 Antitrust Policy as stated in §05.01 of the Governance and Operations Manual (GOM).


Please include your organization in your Zoom name.

  • Click on your picture/name in Zoom
  • Click on rename
  • enter <name> - <organization>
Danielle BancroftBest Practice Software
Melva Peters Jenaker Consultingx
Jean Duteau (Chair)Duteau Designx
John Hatem (Scribe)Independent Consultantx
Scott Robertson Kaiser Permanente
Christof GessnerHL7 Germany
Corey SpearsMITRE
Dave HillMITRE
Frank McKinneyPOCPx
Isaac VetterEpic
Smile CDRx
Lawrence LoColumbia University HIT Student
Margaret WeikerNCPDPx
Matt SzczepankiewiczEpic
Peter SergentHL7 New Zealand
Reed D. GelzerTrustworthy EHR
Shelly SpiroPharmacy HIT Collaborativex
Stephen ChuADHA
Tim McNeilSurescriptsx
Kim RobertsPharmacy HIT Collaborative
Kent BulzaWell Health
Phung Matthews3M
Jack BrashierEpic
Emmanuel Obasuyi

Joel MontavonPQA
Robb YoungPharmID
Christopher Isong

Gary SchoettmerNetRx
Courtney BlandCVS / Aetna
Mark NeumuthAetna
Ed MillikanFDA
Sanket RavalCVS / Aetna

Agenda Items and Notes

Outstanding Action Item List

Meeting Notes from previous meeting

Project Review

Project Proposals

Project Scope Statements

External Meeting Review

Catalog Updates (John Hatem)

  • - no meeting on 9/12, next meeting is on 9/16

Workflow Update (John Hatem) 

  • - unable to attend, will update after minutes are posted. 

Healthcare Product Update (John Hatem)

  • - unable to attend, will update after minutes are posted

EHR conformant reconciled medication list (cRML) (Scott Robertson / John Hatem)

  • - no meeting

NCPDP Updates (NCPDP Members)

All NCPDP Meeting information can be obtained at

  •   - no new NCPDP issues


Pharmacist Consult Note (Scott)

  • - Currently under ballot (closes Sept 12)

Pharmacy Templates

  • - Currently under ballot (closes Sept 12)
    • Georgio will not be attending the WGM, so we may discuss this during one of weekly conference calls

Specialty Medication Enrolment IG

  • - Currently under ballot (closes Sept 12)
    • Frank reported that were several comments at this point.  Stats to be discussed on Monday Q3

Trackers - link to pharmacy unresolved Jira trackers (see trackers for details / resolutions)

  • Update of R5 Pharmacy content - sign up for R5 ballot
  • FHIR-37974 - Motion to accept resolution by John Hatem / Melva Peters  Vote passed:  7-0-0  see tracker for details
  • FHIR-37973 - Motion to accept resolution by Melva Peters / John Hatem  Vote passed:  7-0-0 - see tracker for details

WGM Agenda

WGM Agenda - meeting Mond Q3, Thu Q2, Thu Q4.  Joint with BR&R Mon Q1, Tue Q1.  Attending FHIR-I Tue Q2. Attending PC Wed Q4.  Attending CQI/CDS Thu Q1.

Any Other Business

  • will anyone be able to attend the HL7 Catalog meeting on Sept 16th.  
    • John will send out a link to the meeting to the Pharmacy list serv

Next meeting:

  •  (2nd week after the WGM)